Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05388864 · ClinicalTrials.gov registry record · NA
Building Resilient Families
A NA study of Adverse Childhood Experiences, sponsored by Loma Linda University.
- Recruiting
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 1
- Study location
NCT05388864 is a NA study of Adverse Childhood Experiences that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 340 participants, above the 304-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05388864, a NA study of Adverse Childhood Experiences, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 1
- Study location
Study Summary
Prior research suggests that it is possible to improve health outcomes in children with ACEs through multi-component interventions. The challenge for most communities is that health and education systems are fragmented and fail to accommodate families based upon different levels of need. This study utilizes cross-sectoral partnerships to mobilize three vectors (pediatricians, community health workers and parenting educators) to optimize the delivery of vital information and resources to a diverse population of families with ACEs. All vectors are trained in an evidence-informed curriculum to strengthen families and build youth resilience. The study design is a randomized controlled trial of 340 families of children between the ages of 3 to 11 who are generally healthy and have recently seen a pediatrician for a well-child visit. To evaluate the efficacy of this intervention, pediatric patients are invited to participate in repeat evaluations within 2 weeks, 3 months, 6 months, and 12 months after their well-child visit. The study will evaluate the following: 1) the association between Child-ACE scores and biomarkers of toxic stress at baseline in children age 3-11 years old; 2) whether the intervention reduces toxic stress and child health and psychosocial problems at follow-up for children with ACEs compared to usual well-child care for children with ACEs; and 3) the impact of mediating and moderating variables. These results will demonstrate that for families with ACEs the intervention will decrease toxic stress associated with ACEs, improve health outcomes, and reduce health disparities.
Conditions Studied
Interventions
- BEHAVIORAL Three-Tier Model
Study Locations (1)
California
- Loma Linda University - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2022-05-24 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05388864
The ClinicalTrials.gov registry entry for NCT05388864 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 304-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (12% higher). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adverse Childhood Experiences appearing as the primary indexed condition, and to 1 intervention - of which Three-Tier Model is the first listed.
NCT05388864 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05388864 about?
NCT05388864 is a clinical study titled "Building Resilient Families". Prior research suggests that it is possible to improve health outcomes in children with ACEs through multi-component interventions. The challenge for most communities is that health and education systems are fragmented and fail to accommodate families based upon different levels of need. This study ...
What is the current status of trial NCT05388864?
This trial is currently recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2022-05-24. Estimated completion is 2027-05.
What conditions does trial NCT05388864 study?
This clinical trial studies the following conditions: Adverse Childhood Experiences.
What interventions are being tested in trial NCT05388864?
The interventions under investigation include: Three-Tier Model (BEHAVIORAL).
Who is sponsoring clinical trial NCT05388864?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05388864 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Childhood Experiences
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments
RECRUITING · NA
-
ACEs, SIRT1, and Premature Vascular Aging in Humans
RECRUITING · NA
-
Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program
RECRUITING · NA
-
Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.